VYNE compared with EOLS: revenue, margins and what each company keeps, and the suppliers and customers both name

VYNEVYNE Therapeutics Inc.

Mkt capRevenueRevenue

EOLSEvolus, Inc.

Mkt capRevenueRevenue

Compare

VYNEVYNE Therapeutics Inc.

EOLSEvolus, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only VYNE 0

None

Shared 0

No disclosed counterparties: VYNE.

Only EOLS 3

—Daewoong Pharmaceuticalsunlistedsupplier

—Symateseunlistedsupplier

—Symatese Aesthetics S.A.Sunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

VYNEVYNE Therapeutics Inc.

13.63▼−8.57%· post 13.64

Mkt cap—Revenue—Revenue—

EOLSEvolus, Inc.

6.82▼−8.77%· post 6.83

ClosedNov 5 '26

Mkt cap$494.4MRevenue$78MQ3 FY26Revenue$297MFY25

Compare

ClosedNov 5 '26

VYNEVYNE Therapeutics Inc.

EOLSEvolus, Inc.

13.63▼−8.57%post 13.64

Price

6.82▼−8.77%post 6.83

—

Mkt cap

$494.4M

—

Revenue

$78MQ3 FY26

—

Revenue

$297MFY25

VYNE13.63▼−8.57%vsEOLS6.82▼−8.77%ClosedNov 5 '26